Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the ...
TD Cowen raised the firm’s price target on DraftKings (DKNG) to $60 from $51 and keeps a Buy rating on the shares. The firm raised its ...
TD Cowen cut shares of Akamai Technologies (NASDAQ:AKAM – Free Report) from a buy rating to a hold rating in a report issued ...
TD Cowen initiated coverage of Centessa (CNTA) with a Buy rating and no price target The firm says the company’s ORX750 has a “best in class profile as a transformative therapy” in excessive ...
Snowflake (NYSE:SNOW) was in the spotlight on Friday as TD Cowen said recent partner checks were “constructive” ahead of the data processing and warehouse company's fourth-quarter results next ...
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio, today announced that members of its management team will participate in the TD Cowen 2nd ...
MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced ...
Inozyme Pharma is a pioneering clinical-stage biopharmaceutical company dedicated to developing innovative therapeutics for rare diseases that affect bone health and blood vessel function. We are ...
In a report released today, Josh Jennings from TD Cowen maintained a Hold rating on Becton Dickinson (BDX – Research Report), with a price ...